Evolent Health
ARLINGTON, Virginia, United States · Health Care, Medical, Other
Evolent Health, Inc. specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. The company serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally.
Key facts
- Headquarters
- ARLINGTON, Virginia, United States
- Employees
- 3,865
- Industries
- Health Care, Medical, Other
- Status
- Public (EVH)
- Website
- evolenthealth.com
- Company page
Recent activity at Evolent Health
- : SEC 8-K (5.07): On June 4, 2026, Evolent Health, Inc. held its 2026 Annual Meeting of Stockholders, during which the stockholders successfully elected ten director nominees to the Board of Directors for a one-year term. This meeting is significant as it reflects a change in the governance structure of the Company with potential implications for strategic direction and leadership. Voting results and proposals were detailed in the definitive proxy statement filed on April 24, 2026, and the implications of these elections could influence the company's strategic decisions for the coming year.
- : Evolent Health Appoints Archie Mayani as Chief Product Officer
- : SEC 8-K (8.01): On December 5, 2025, Evolent Health LLC, a wholly owned subsidiary of Evolent Health, Inc., completed the transactions outlined in the Stock Purchase Agreement dated September 23, 2025, with Privia Management Company, LLC. This transaction likely represents a significant strategic move for Evolent Health, indicating growth and expansion into new areas or services through the acquisition of assets or interests from Privia Management. The completion date of December 5 is crucial as it indicates the immediate impact on the company's operations and financials, which may affect stakeholder perception and future financial reporting. However, specific financial details and terms of the agreement have not been disclosed in this filing.
- : SEC 8-K (8.01): On December 5, 2025, Evolent Health LLC, a wholly owned subsidiary of Evolent Health, Inc., completed the transactions outlined in a Stock Purchase Agreement dated September 23, 2025, with Privia Management Company, LLC. This acquisition signifies Evolent Health's strategic move to enhance its capabilities in the healthcare sector. The exact financial terms of the transaction have not been disclosed in this report, but it represents a significant expansion for Evolent Health. The completion of this agreement marks a pivotal step in Evolent's growth strategy and is expected to strengthen their market position moving forward.
- : SEC 8-K (5.02): On December 1, 2025, Ms. Cheryl Scott retired from the Board of Directors of Evolent Health, Inc., with the retirement not stemming from any disagreement with the company. In connection with her retirement, the Board accelerated the vesting of 21,979 restricted stock units originally set to vest in 2026. Following this, on December 2, 2025, the Board appointed Ms. Jill Smith to fill the vacancy, with her term extending until the 2026 Annual Meeting. Ms. Smith brings extensive leadership experience and has served in various significant roles in the technology sector. She is recognized as an independent director, with no relationships that could impair her independence as per SEC rules.
- : SEC 8-K (5.02): On December 1, 2025, Ms. Cheryl Scott retired from the Board of Directors of Evolent Health, Inc. Her retirement was amicable and not due to any disagreements regarding the Company's operations. The Board accelerated the vesting of 21,979 restricted stock units that were originally scheduled to vest on June 5, 2026. This action is part of the Company's approach to compensate its departing board members. The strategic impact of this change may influence future governance and decision-making processes within the Company.
- : SEC 8-K (5.02): On November 6, 2025, the Company announced significant changes in its leadership team, specifically the appointment of Mario Ramos as Chief Financial Officer, effective January 1, 2026. Mr. Ramos previously held notable positions at various companies, including Chief Financial Officer at WellBe Senior Medical and CVS Caremark. His annual base salary is set at $550,000 with a potential cash bonus of $625,000 based on performance metrics. Additionally, he will receive a sign-on bonus of $100,000 and a one-time restricted stock unit grant valued at $2,350,000, subject to vesting terms. This restructuring aims to strengthen the Company's financial leadership in anticipation of upcoming strategic goals.
- : Evolent Health Appoints Dr. David Lim as Chief Clinical Officer and John Way as CFO
- : Dr. Von Nguyen Appointed as Chief Medical Officer at Evolent Health, Inc.
- : Humana and Evolent Expand Partnership to Modernize Oncology Care Processes
Evolent Health funding history
| Date | Round | Amount |
|---|---|---|
| May 2023 | Seed | $728K |
| Aug 2022 | Venture | $125.0M |
| Nov 2021 | Seed | $450K |
| Oct 2021 | Venture | $42.5M |
| Jun 2019 | Seed | $1.3M |
Leadership
- Saagar Vadge, Associate Director Total Rewards and Operations
- MICHAEL D'AMATO, Director
- FRANK WILLIAMS, Executive Officer, Director
- TUNDE SOTUNDE, Director
- DAVID FARNER, Director
- CRAIG BARBAROSH, Director
- BRIDGET DUFFY, Director
- PETER GRUA, Director
- DIANE HOLDER, Director
- KIM KECK, Director
- CHERYL SCOTT, Director
- SETH BLACKLEY, Executive Officer, Director
Verified email and direct lines for Evolent Health’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Evolent Health files 4 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Evolent Health in the news
- EVOLENT HEALTH ANNOUNCES ACQUISITION OF SPECIALTY ASSET NIA AND STRATEGIC PARTNERSHIP WITH CENTENE - PR Newswire (Nov 17, 2022)
- Evolent Health announces focus on value-based specialty care with rebrand, unification of all solutions under "Evolent" - PR Newswire (Jul 11, 2023)
- EVOLENT HEALTH TO ACQUIRE IPG - PR Newswire (Jun 29, 2022)
Companies similar to Evolent Health
- Ascension Borgess · Health Care, Medical, Other
- Tilray Brands · Health Care, Medical, Other
- Trulieve · Health Care, Medical, Other
- Registrar · Health Care, Medical, Other
- Lifecore Biomedical · Health Care, Medical, Other
About Evolent Health: questions and answers
What does Evolent Health do?
Evolent Health, Inc. specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. The company serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally.
Where is Evolent Health headquartered?
Evolent Health is headquartered in ARLINGTON, Virginia, United States.
How many employees does Evolent Health have?
Evolent Health has about 3,865 employees.
Has Evolent Health raised funding?
Yes. Fundz has recorded 5 funding events for Evolent Health. The most recent, Seed of $728K, was in May 2023.
What is the latest news on Evolent Health?
On Jun 04, 2026, SEC 8-K (5.07): On June 4, 2026, Evolent Health, Inc. held its 2026 Annual Meeting of Stockholders, during which the stockholders successfully elected ten director nominees to the Board of Directors for a one-year term. This meeting is significant as it reflects a change in the governance structure
Is Evolent Health a public company?
Yes. Evolent Health is publicly traded under the ticker EVH.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy